Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methylprednisolone hemisuccinate
Drug ID BADD_D01435
Description A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.
Indications and Usage Adjunctive therapy for short-term administration in rheumatoid arthritis.
Marketing Status Prescription; Discontinued
ATC Code D07AA01; D10AA02; H02AB04
DrugBank ID DB14644
KEGG ID D05000
MeSH ID D008776
PubChem ID 16923
TTD Drug ID Not Available
NDC Product Code 57582-012; 24002-0015; 82298-109; 22552-0024; 52128-152
Synonyms Methylprednisolone Hemisuccinate | Hemisuccinate, Methylprednisolone | Methylprednisolone Succinate | Succinate, Methylprednisolone | Urbason-Soluble | UrbasonSoluble | Solu-Medrol | Solumedrol | A-MethaPred | Methylprednisolone Sodium Succinate | Sodium Succinate, Methylprednisolone | Methylprednisolone Hemisuccinate Monosodium Salt | 6 alpha-Methylprednisolone Sodium Hemisuccinate | Methylprednisolone Sodium Hemisuccinate | Sodium Hemisuccinate, Methylprednisolone
Chemical Information
Molecular Formula C26H34O8
CAS Registry Number 2921-57-5
SMILES CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cardio-respiratory arrest02.03.04.002; 22.02.06.0070.014597%Not Available
Cardiogenic shock24.06.02.006; 02.05.01.0030.003649%Not Available
Cataract06.06.01.0010.034973%
Cataract subcapsular06.06.01.002--Not Available
Cellulitis11.02.01.001; 23.09.01.0010.027978%Not Available
Cerebellar syndrome17.02.02.0020.013989%Not Available
Cerebral venous thrombosis24.01.04.005; 17.08.03.0020.041967%Not Available
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Chest discomfort22.02.08.001; 08.01.08.019; 02.02.02.0090.125902%Not Available
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.0110.097924%Not Available
Chills15.05.03.016; 08.01.09.0010.279783%
Choking22.02.05.0010.013989%Not Available
Cholelithiasis09.03.01.0020.013989%Not Available
Cholestasis09.01.01.0010.034973%Not Available
Chronic obstructive pulmonary disease22.03.01.0070.005474%Not Available
Circulatory collapse24.06.02.0010.013989%Not Available
Cold sweat23.02.03.002; 08.01.03.0240.020984%Not Available
Colitis07.08.01.0010.020984%
Colitis ulcerative10.02.01.004; 07.08.01.0050.020984%Not Available
Coma17.02.09.001--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Constipation07.02.02.001--
Cough22.02.03.0010.118908%
Crying12.02.11.001; 08.01.03.005; 19.04.02.002; 17.02.05.0130.027978%Not Available
Cushingoid24.08.02.004; 19.07.03.001; 14.11.01.006; 05.01.01.0020.034973%
Cyanosis22.02.02.007; 02.01.02.002; 24.03.01.0070.111913%
Cytomegalovirus infection11.05.01.0020.007299%
Deafness04.02.01.0010.013989%Not Available
Death08.04.01.001--
Dehydration14.05.05.001--
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 17 Pages